Adjunctive chromosomal abnormalities in Philadelphia-negative cells of CML patients treated with Imatinib.
Cervetti
G
G
Galimberti
S
S
Fazzi
R
R
Papineschi
F
F
Azzarà
A
A
Simi
P
P
Petrini
M
M
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001549:Benzamides; D002869:Chromosome Aberrations / Q000139:chemically induced*; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000009:adverse effects*; D011743:Pyrimidines / Q000009:adverse effects*
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate